Citation 69806

OKUYAMA,E: GAO,LH: YAMAZAKI,M:. (1992). ANALGESIC COMPONENTS FROM BORNEAN MEDICINAL PLANTS, TABERNAEMONTANA PAUCIFLORA BLUME AND TABERNAEMONTANA PANDACAQUI POIR.. 40(8)

Citation Details

Title	ANALGESIC COMPONENTS FROM BORNEAN MEDICINAL PLANTS, TABERNAEMONTANA PAUCIFLORA BLUME AND TABERNAEMONTANA PANDACAQUI POIR.
Authors	OKUYAMA,E: GAO,LH: YAMAZAKI,M:
Year	1992
Volume	40
Issue	8

Summary

Year: 1992

Journal: Unknown

Organisms and Their Experiments (2)

Tabernaemontana pauciflora (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANALGESIC ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	HYPOTHERMIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
4	ANALGESIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	CORONARIDINE	None
6	HYPOTHERMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE	ACTIVE
7	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE	ACTIVE
8	LOCOMOTOR ACTIVITY DECREASE	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE	INACTIVE
9	BARBITURATE POTENTIATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE	INACTIVE
10	ANESTHETIC ACTIVITY(LOCAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	CORONARIDINE,3-(2-OXO-PROPYL):	None
12	HYPOTHERMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE,3-(2-OXO-PROPYL):	INACTIVE
13	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE,3-(2-OXO-PROPYL):	WEAK ACTIVITY
14	ANTIHYPERKERATOSIS ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE,3-(2-OXO-PROPYL):	INACTIVE
15	BARBITURATE POTENTIATION	PHARMACOLOGY OF COMPOUND - IN VIVO	CORONARIDINE,3-(2-OXO-PROPYL):	INACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CORONARIDINE,5(R)-(2-OXO-PROPYL):	None
17	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CORONARIDINE,5(S)-(2-OXO-PROPYL):	None
18	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	VOACANGINE,3-(2-OXO-PROPYL):	None
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	CORONARIDINE,3-3'-(OXO-PROPYL)-DI:	None

Tabernaemontana pandacaqui (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATACD SPECTRUM REPORTED FOR	VOACANGINE	None
2	HYPOTHERMIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	VOACANGINE	ACTIVE
3	ANALGESIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	VOACANGINE	ACTIVE
4	ANESTHETIC ACTIVITY(LOCAL)	PHARMACOLOGY OF COMPOUND - IN VIVO	VOACANGINE	ACTIVE

Show SPARQL Queries (1)